GMTX - Gemini Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $-5.74. This is a potential upside of $-5.74 (0%) from yesterday's end of day stock price of $0.

Gemini Therapeutics's activity chart (see below) currently has 9 price targets and 9 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 38.89% with an average time for these price targets to be met of 40.33 days.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 11-Mar-2022. First documented stock forecast 08-Oct-2021.

Best performing analysts who are covering GMTX - Gemini Therapeutics:

Marc Goodman Chris Howerton Paul Matteis Andrew Fein Graig Suvannavejh Matthew Caufield

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$5

$-14.89 (-74.86%)

$20

2 years 8 months 10 days ago
(11-Mar-2022)

1/2 (50%)

$-10 (-66.67%)

33

Buy

$5

$-14.89 (-74.86%)

$5

2 years 8 months 10 days ago
(11-Mar-2022)

1/3 (33.33%)

$-10 (-66.67%)

34

Buy

$10

$-9.89 (-49.72%)

2 years 8 months 18 days ago
(03-Mar-2022)

1/2 (50%)

$-3.4 (-25.37%)

64

Buy

$23

$3.11 (15.64%)

2 years 8 months 20 days ago
(01-Mar-2022)

0/1 (0%)

$10.05 (77.61%)

Hold

$11

$-8.89 (-44.70%)

$11

2 years 8 months 24 days ago
(28-Feb-2022)

0/2 (0%)

$-2.6 (-19.12%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GMTX (Gemini Therapeutics) average time for price targets to be met?

On average it took 40.33 days on average for the stock forecasts to be realized with a an average price target met ratio 38.89

Which analyst has the current highest performing score on GMTX (Gemini Therapeutics) with a proven track record?

MARC GOODMAN

Which analyst has the current lower performing score on GMTX (Gemini Therapeutics) with a proven track record?

MATTHEW CAUFIELD

Which analyst has the most public recommendations on GMTX (Gemini Therapeutics)?

Marc Goodman works at LEERINK and has 9 price targets and 7 ratings on GMTX

Which analyst is the currently most bullish on GMTX (Gemini Therapeutics)?

Chris Howerton with highest potential upside - $3.11

Which analyst is the currently most reserved on GMTX (Gemini Therapeutics)?

Andrew Fein with lowest potential downside - -$14.89

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?